Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Cardiovascular Therapeutics|January 13, 2022
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure PopulationErik Håkansson, Helena Norberg, Sara Själander, et al.European Journal of Clinical Pharmacology|January 4, 2020
Differences in medical treatment and clinical characteristics between men and women with heart failure - a single-centre multivariable analysisHelena Norberg, Veronica Pranic, Ellinor Bergdahl, et al.Cardiovascular Therapeutics|July 19, 2018
Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure populationAnna Jonsson, Helena Norberg, Ellinor Bergdahl, et al.European Journal of Clinical Pharmacology|August 22, 2020
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case studyHelena Norberg, Ellinor Bergdahl, Karin Hellström Ängerud, et al.Open Heart|January 5, 2023
Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional studyErik Håkansson, Mattias Brunström, Helena Norberg, et al.Acta Ophthalmologica|October 14, 2024
Faricimab versus bevacizumab for neovascular age-related macular degeneration: Cost analysis based on real-world data from the Swedish Macula RegistrySouad Abdalla, Inger Westborg, Anni-Maria Pulkki-Brännström, et al.Pharmacy (Basel, Switzerland)|May 5, 2018
Older Peoples' Adherence and Awareness of Changes in Drug Therapy after Discharge from HospitalSara Norberg, Maria GustafssonDrugs - Real World Outcomes|May 21, 2017
Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern SwedenCecilia Peterson, Maria GustafssonCurrent Opinion in Lipidology|September 14, 2004
Mechanism of lipoprotein retention by the extracellular matrixMaria Gustafsson, Jan BorénResearch in Social & Administrative Pharmacy : RSAP|June 10, 2019
Prevalence of drug-related problems using STOPP/START and medication reviews in elderly patients with dementiaLinnea Abramsson, Maria GustafssonPageof 11